Novartis AG (NVS)
130.17
-1.99
(-1.51%)
USD |
NYSE |
Dec 08, 16:00
132.86
+2.69
(+2.07%)
Pre-Market: 06:54
Novartis Shareholders Equity (Quarterly): 44.33B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Roche Holding AG | -- |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Avidity Biosciences, Inc. | 1.886B |
| Monte Rosa Therapeutics, Inc. | 245.84M |
| Tourmaline Bio, Inc. | 259.19M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 107.29B |
| Total Liabilities (Quarterly) | 62.54B |
| Debt to Equity Ratio | 0.7224 |
| Current Ratio | 0.8812 |
| Net Debt Paydown Yield | -0.25% |